Skip to content

Mind the Medicine Gap: Track 1

Featuring: Audio Audio

This page was published over five years ago. Please be aware that due to the passage of time, the information provided on this page may be out of date or otherwise inaccurate, and any views or opinions expressed may no longer be relevant. Some technical elements such as audio-visual and interactive media may no longer work. For more detail, see our Archive and Deletion Policy

Vanessa lives in London. She has cancer. Lemlem lives in rural Ethiopia. She has typhoid. Most people would agree that both women should have similar access to the medicines they need. But why is this harder for Lemlem? And why are fewer drugs developed for common diseases in Lemlem's part of the world? Is it that the pharmaceutical companies are driven only by a profit motive? Is it because of failing infrastructure in developing countries? Or are there more subtle answers? In this feature Keren Bright of The Open University investigates the idea that the patent system is too blunt an instrument to serve the interests of both pharmaceutical companies and the poor like Lemlem. There are smart solutions though; ways for everybody to win. Big questions. Fascinating answers.

By: The OpenLearn team (The Open University,)

  • Duration 20 mins
  • Updated Thursday 16th September 2010
  • Posted under Law
Share on LinkedIn View article Comments
Print

Track 1: Mind the Medicine Gap

An insight to why people in poor countries have less access to medicines.


© The Open University 2010


Tracks in this podcast:

Track   Title Description
1 Mind the Medicine Gap    An insight to why people in poor countries have less access to medicines. Play now Mind the Medicine Gap

Author

Share

Related content (tags)

Copyright information